Apremilast

Pneumonia: case report

    This is a preview of subscription content, access via your institution.

    Reference

    1. del Alcazar E, et al. Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group. Journal of the European Academy of Dermatology and Venereology 34: 2821-2829, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1111/jdv.16439

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Apremilast. Reactions Weekly 1843, 57 (2021). https://doi.org/10.1007/s40278-021-91159-2

    Download citation